
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.
Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.
Deborah Michaelson, MS, RPh, discusses various challenges that accompany patient support in the long-term care setting.
Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how specialty pharmacy can best utilize data analytics.
Eric Peacock, CEO of MyHealthTeams, discusses how the role patients take in their own care is rapidly evolving in the technological era.
Daniel P. Kus, BS Pharm, RPh, discusses how specialty pharmacies can help patients manage out-of-pocket drug spending.
Sheila Arquette, RPh, discusses the importance of obtaining accreditation for specialty pharmacy.
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Mark Tesell, PharmD, BCPS, discusses trends that could impact specialty pharmacy well into the future.
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies can best demonstrate value as health care transitions to a value-based system.
Rinku A. Patel, PharmD, RPh, founder and CEO at KloudScipt, discusses effective integration of technology in the pharmacy setting.
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses how specialty stakeholders can take steps to improve the perception surrounding specialty pharmacies following recent drug cost controversies.
John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how to improve the relationship between specialty pharmacies and specialty drug manufacturers.
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.
Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty pharmacies can navigate limited distribution networks.
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, explains how immunization recommendations are made.
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses the challenges health care professionals face in implementing vaccine recommendations.
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about invasive disease prevention.
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses misconceptions about vaccinations.
John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about why it's important for children to receive their recommended immunizations.